BKG-PHARMA ApS: Financial statements 2013
CVR: 27959350
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
BKG-PHARMA ApS (CVR 27959350) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK 937,848 and a net result of DKK 791,513 compared with DKK 535,020 the year before. That is an increase of 12.1% compared with the year before. Equity in the 2013 report amounted to DKK 14,548,065. The solvency ratio was 92.2%.
- Gross Profit
- DKK 937,848
- Profit/Loss
- DKK 791,513
- Equity
- DKK 14,548,065
- Total Assets
- DKK 15,777,333
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | - | 938 t. | 792 t. | 14.5 mio. | - |
| 2012 | - | 837 t. | 535 t. | 13.8 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
BKG-PHARMA ApS has published its annual report for 2012. Gross profit came to DKK 836,978, and the net result was DKK 535,020.
About BKG-PHARMA ApS
BKG-PHARMA ApS was a Danish company of the type Anpartsselskab based in Klampenborg, founded in 2004. The company has been dissolved on 27 December 2017. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. The company has 0 employees (2018). In 2016, the company reported a gross profit of DKK -616,406 and a net result of DKK -18,025,433 compared with DKK -94,523 the year before. Equity in the 2016 report amounted to DKK -2,682,678.